1. Introduction
===============

Height is an indicator of population health^\[[@R1]\]^ and is representative of childhood health and nutritional status, despite the related genetic component after the adolescent growth spurt.^\[[@R2],[@R3]\]^ Adult height decreases as part of the aging process. The exact mechanisms of this height loss have not been fully elucidated; nonetheless, the phenomenon is associated with several biological and pathophysiological changes, including increased fat mass, decreased fat-free mass, and reduced bone mineral density.^\[[@R4]\]^ Furthermore, degenerative changes in the intervertebral discs, vertebral deformity or fracture, and senile kyphosis can cause height loss.^\[[@R5]--[@R7]\]^ In some studies, height loss has also been associated with clinical issues such as decreased cognitive function and self-reported health status, depression, and illness.^\[[@R8]--[@R11]\]^ Indeed, 1 cohort study found that an annual height loss of \>1 cm per year increased the risk of bone fracture;^\[[@R12]\]^ another found that a height loss of \>3 cm over 20 years increased both mortality and the incidence of coronary heart disease.^\[[@R13]\]^ In addition to these medical issues, several investigations have found an effect of childhood socioeconomic status (SES) on adult health status, as it relates to height.^\[[@R14]--[@R18]\]^

In general, the prevalence and mortality of chronic diseases are negatively associated with SES,^\[[@R19]--[@R24]\]^ and several Chinese studies found that height loss was negatively associated with SES in both adulthood^\[[@R25]\]^ and childhood.^\[[@R26]\]^ However, this relationship has not been investigated in the South Korean population. Therefore, we examined the average height loss and relationship between height loss and SES among the elderly in South Korea using representative sample data from the Korean National Health and Nutrition Examination Survey (KNHANES).

2. Methods
==========

2.1. Survey overview
--------------------

The KNHANES has been conducted by the Division of Chronic Disease Surveillance at the Korean Center for Disease Control and Prevention since 1998. It surveys the health and nutrition of the population at a national level and is divided into 3 parts: a health interview, physical examination, and nutritional survey.^\[[@R27]\]^ We used data from the KNHANES conducted between 2008 and 2010. A representative sample of noninstitutionalized civilians was obtained from all geographic regions in the country; subjects were selected using a cluster sampling design, stratified into multiple stages, and prorated by age as stated in the 2005 National Census Registry. Trained interviewers performed face-to-face interviews.

2.2. Subjects
-------------

In total, 29,235 subjects participated in the 2008--2010 KNHANES. We enrolled men \>50 years old and postmenopausal women (n = 7564) and excluded those who had not answered the questions concerning medical history or had not fasted for \>8 hours before the measurement (n = 2299). Finally, 5265 subjects (2818 men and 2447 women) were included in the study. The institutional review board of the Korean Center for Disease Control and Prevention approved the study protocol. Written informed consent forms were obtained from all subjects.

2.3. Anthropometric and biochemical measurements
------------------------------------------------

Current height and weight were measured without shoes and with only light clothes to the nearest 0.1 cm and 0.1 kg, respectively, by a trained examiner using quality-controlled measuring instruments. The subjects' lifetime maximum height was determined using the self-reported questionnaire. Height loss was calculated as the difference between the maximum height and current height. Then, subjects were divided into 4 quartiles on the basis of their height loss: Q1 (\<0.1 cm), Q2 (0.1--1.2 cm), Q3 (1.2--2.6 cm), and Q4 (≥2.6 cm) for men and Q1 (\<0.9 cm), Q2 (0.9--2.3 cm), Q3 (2.3--3.9 cm), and Q4 (≥3.9 cm) for women. After normal expiration, waist circumference (WC) was measured to the nearest 0.1 cm on a horizontal plane at the mid-point between the lower costal margin and the iliac crest. Weight (kg) was divided by height squared (m^2^) to calculate the body mass index (BMI). Blood pressure (BP) was measured 3 times at 5-min intervals using a standard mercury sphygmomanometer (Baumanometer; W.A. Baum Co., New York), with the subject seated. The mean of the second and third measurements was calculated and used in the analysis. Blood samples were collected after the subject had fasted for ≥8 hours. The fasting serum levels of glucose, triglyceride, and high-density lipoprotein cholesterol (HDL-C) were measured enzymatically using a Hitachi Automatic Analyzer 7600 (Hitachi, Tokyo, Japan).

2.4. Socio-demographic variables
--------------------------------

Socio-demographic variables (age, sex, education level, family income level, and occupation) were surveyed with the self-reported questionnaire. We divided subjects into 3 groups according to the education level and the income: low \[income (iQ1) and education ≤6 years\], middle \[income (iQ2--3) and education 7--12 years\], and high \[income (iQ4) and education ≥13 years\].

2.5. General health behaviors
-----------------------------

Those who drank ≥30 g/day of alcohol were classified as heavy drinkers. Current smokers were defined as those who currently smoked and had smoked at least 100 cigarettes in their whole life. Physical activity was determined using the International Physical Activity Questionnaire (8). The "regular exercise" group included those who exercised ≥3 times/week for ≥20 min/session (in the case of intense exercise), or for ≥30 min/session.

2.6. Definition of metabolic syndrome
-------------------------------------

Metabolic syndrome was defined using the American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (AHA/NHLBI) for Asians.^\[[@R28],[@R29]\]^ Subjects who had more than 3 of the following components were defined as having metabolic syndrome: high WC (≥90 cm in men or ≥80 cm in women), high fasting blood glucose level (≥100 mg/dL) or use of a hypoglycemic drug, high BP (≥130/85 mmHg) or use of an antihypertensive drug, low HDL-C level (\<40 mg/dL in men or \<50 mg/dL in women) or use of an antidyslipidemic drug, and high triglyceride level (≥150 mg/dL) or use of an antidyslipidemic drug.

2.7. Statistical analyses
-------------------------

Data are presented as mean ± standard error (SE) for continuous variables and as percentages (SE) for categorical variables. To analyze the subjects' general characteristics, Student\'s *t*-test was used for continuous variables, and the Chi-square test was used for categorical variables. Analysis of covariance was used to examine height loss among the 3 SES groups and among the 3 age groups (50--59 years, 60--69 years, and ≥70 years). Three multivariable-adjusted logistic regression analysis models were performed to determine the odds ratios (ORs) and 95% confidence intervals (CIs) of the prevalence of maximum (Q4) height loss in each quartile of education level and income. More specifically, model 1 was adjusted for age, and model 2 was adjusted for age, BMI, smoking, drinking, regular exercise, occupation, and metabolic syndrome. We also examined the OR and 95% CI for height loss (Q4) in each of the 3 SES groups, in both men and women, after adjusting for all covariates. We used the SAS software package version 9.2 for Windows (SAS Institute Inc., Cary, NC) to provide approximations for the whole Korean population and to account for the complex sampling design. All statistical tests were 2-tailed, and *P*-values \<.05 were considered statistically significant.

3. Results
==========

3.1. General characteristics of the subjects
--------------------------------------------

In both men and women, we compared the general characteristics of the subjects divided into two groups: "less height loss" (Q1--3) and "maximum height loss" (Q4) (Table [1](#T1){ref-type="table"}). Both men and women in the Q4 group were older than those in the Q1--3 group (both *P* \< .001). The mean height, weight, BMI, WC, and occupation rate were higher in the Q1--3 group in men. In women, mean height, weight, BMI, and regular exercise were higher, but WC and the prevalence of metabolic syndrome were lower in the Q1--3 group than in the Q4 group (all *P* \< .05). In men, the mean maximum height in the Q1--3 group was 168.8 ± 0.1 cm and in the Q4 group was 168.0 ± 0.2 cm (*P* = .016), and the mean height loss was 0.5 ± 0.0 cm in the Q1--3 group and 4.3 ± 0.1 cm in the Q4 group (*P* \< .001). In women, the mean maximum height was 157.1 ± 0.1 cm in the Q1--3 group and 157.7 ± 0.2 in the Q4 group (*P* = .004), and the mean height loss was 1.5 ± 0.0 cm in the Q1--3 group and 6.4 ± 0.1 cm in the Q4 group (*P* \< .001).

###### 

General characteristics of the subjects from the KNHANES.
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3.2. Proportions of each SES group in the Q1--3 and Q4 groups
-------------------------------------------------------------

Table [2](#T2){ref-type="table"} shows the proportions of the Q1--3 and Q4 groups in each SES group, in men and women. The proportions of the subjects in each SES group were significantly different between the Q1--3 and Q4 groups in men and women (all *P* \< .001). In the Q1--3 groups, a higher proportion of subjects had ≥13 years of education than in the Q4 groups (men: 22.4% vs 11.0% and women: 7.3% vs 3.3%). Conversely, a lower proportion of subjects in the Q1--3 groups had ≤6 years of education than in the Q4 groups (men: 25.8% vs 41.4% and women: 48.2% vs 69.4%). A similar proportional distribution was observed in both men and women with regard to the income level. In the Q1--3 groups, a higher proportion of subjects had the highest income level (iQ4) than in the Q4 groups (men: 32.1% vs 18.6% and women: 24.8% vs 14.1%). In the Q4 groups, a higher proportion of subjects had the lowest income level (iQ1) than in the Q1--3 groups (men: 17.2% vs 36.7% and women: 21.9% vs 44.8%).
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Proportions of men and women in each education and income group, in the Q1--3 and Q4 groups for height loss.
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3.3. Mean height loss among the 3 SES groups according to the 3 age groups
--------------------------------------------------------------------------

In both men and women, mean height loss increased as the age increased, and mean height loss was higher in the low SES group than in the high SES group among all 3 age groups (50--59 years, *P* = .006; 60--69 years, *P* = .004; and ≥70 years, *P* = .002 in men and 50--59 years, *P* = .005; 60--69 years, *P* = .004; and ≥70 years: *P* \< .001 in women) (Fig. [1](#F1){ref-type="fig"}).

![Mean height loss in the 3 socioeconomic status (SES) groups according to the age group in men: 50--59 years, *P* = .006; 60--69 years, *P* = .004; and ≥70 years, *P* = .002. SES groups: low (income iQ1 and ≤6 years of education), middle (income iQ2--3 and 7--12 years of education), and high (income iQ4 and ≥13 years of education). (B) Mean height loss in the 3 socioeconomic status (SES) groups according to age group in women: 50--59 years, *P* = .005; 60--69 years, *P* = .004; and ≥70 years: *P* \< .001. SES groups: low (income iQ1 and ≤6 years of education), middle (income iQ2--3 and 7--12 years of education), and high (income iQ4 and ≥13 years of education). iQ = income quartiles, SES = socioeconomic status.](medi-96-e7131-g003){#F1}

3.4. Prevalence of maximum height loss (Q4) according to SES
------------------------------------------------------------

Table [3](#T3){ref-type="table"} shows the prevalence of maximum height loss (Q4) according to SES. Compared with the highest education level (≥13 years; reference group), the prevalences of maximum height loss (Q4) were 2.16, 1.83, and 1.49 times more prevalent in the men with ≤6 years, 7--9 years, or 10--12 years of education, respectively, after adjustment for all covariates. These ORs for the prevalence of height loss (Q4) tended to increase as the education level decreased (*P* \< .001). The prevalence of height loss (Q4) was not associated with education level in women; however, there was a tendency for the ORs for the prevalence of height loss (Q4) to increase as the education level decreased (*P* \< .001).
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Multivariable-adjusted logistic regression analysis of the prevalence of maximum height loss (Q4) according to socioeconomic status in men and women.
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In the relationship between the income level and the maximum height loss (Q4), the subjects with the lowest income level (iQ1) were 2.03 and 1.94 times more likely to have maximum height loss (Q4) than the subjects with the highest income level (iQ4) in men and women, respectively, after adjusting for all covariates. Moreover, in both men and women, as the income level decreased, the ORs for the prevalence of maximum height loss (Q4) increased (*P*-value for both trends \<.001).

3.5. Prevalence of maximum height loss (Q4) among the 3 SES groups
------------------------------------------------------------------

Using multivariable-adjusted logistic regression analysis, we additionally analyzed the ORs and 95% CIs for the prevalence of maximum height loss (Q4) in the 3 SES groups in men and women (Fig. [2](#F2){ref-type="fig"}). After adjustment for all covariates, maximum height loss (Q4) was 1.705 times more prevalent in the men in the low SES group and 0.330 times less prevalent in the men in the high SES group than men in the middle SES group. In women, maximum height loss (Q4) was 1.537 times more prevalent in the women in the low SES group than in the women in the middle SES group after adjustment for all covariates.

![Prevalence of maximum (Q4) height loss among the 3 socioeconomic status (SES) groups in men and women. Odds ratios and 95% confidence intervals (CIs) were obtained using multivariable-adjusted logistic regression, adjusted for age, body mass index, smoking, drinking, regular exercise, occupation, and metabolic syndrome. *P* value for trend \<.001 in both men and women. Q4: the highest quartile of height loss. SES groups: low (income iQ1 and ≤6 years of education), middle (income iQ2--3 and 7--12 years of education), and high (income iQ4 and ≥13 years of education). CIs = confidence intervals, iQ = income quartiles, Q4 = highest quartile of height loss, SES = socioeconomic status.](medi-96-e7131-g005){#F2}

4. Discussion
=============

In the present study, height loss was associated with SES level among all age groups, and mean height loss increased as age increased. In the relationship between the education level and the maximum height loss (Q4), men with ≤6, 7--9, or 10--12 years of education had a higher prevalence of maximum height loss (Q4) overall than men with the highest education level. Regarding the relationship between the income level and maximum height loss (Q4), the men and women with the lowest income level were 2.03 and 1.94 times more likely, respectively, to have maximum height loss (Q4) than the subjects with the highest income level.

Height loss is associated with overall mortality independent of vertebral fracture.^\[[@R5],[@R7],[@R13]\]^ Wannamethee et al^\[[@R13]\]^ found that elderly men with a height loss ≥3 cm were at an increased risk of all-cause mortality and coronary heart disease. Another study found that women with height loss \>5 cm had poor health outcomes,^\[[@R7]\]^ because height loss might compress internal organs, such as those in the respiratory, cardiovascular, and gastrointestinal systems, resulting in decreased function, early satiety, and consequent weight loss.^\[[@R30]\]^

Although controversies exist regarding the relationship between height loss and bone mineral density, several studies have suggested that height loss is associated with decreased bone mineral density and osteoporosis.^\[[@R4],[@R31],[@R32]\]^ Moreover, Kantor et al^\[[@R32]\]^ found that height loss ≥2 inches was a strong predictor of osteoporosis at the hip. In addition to height loss, SES is also a risk factor for osteoporosis. A higher education level has a protective effect on bone mineral density, although no linear relationship was found in a population-based study involving women.^\[[@R33]\]^ The exact mechanism of this is not known; it is possible that people with a higher education level are more likely to exercise and use nutritional supplementation than people with a lower education level.^\[[@R34]\]^ Moreover, social position during childhood might affect bone mineral density as well as height in adulthood.^\[[@R18]\]^ Studies that analyzed the relationship between SES and bone mineral density screening found that subjects with lower income were less likely to undergo bone mineral density screening.^\[[@R35],[@R36]\]^ This might delay the diagnosis and treatment of osteoporosis and fracture and subsequently result in height loss. Other studies have emphasized a cumulative effect of bone health from childhood or pre-birth; in subjects with low SES, these effects may deteriorate bone health.^\[[@R37]--[@R40]\]^

Issues in the cartilage and joints of the spine might cause height loss. Indeed, 25% of the spinal column height comprises intervertebral discs; therefore, a degenerative change in the discs would result in height loss, especially in the elderly.^\[[@R41],[@R42]\]^ Because the diagnosis and treatment of degenerative diseases may also be delayed in subjects with low SES, these degenerative changes are more prevalent in these subjects.^\[[@R43],[@R44]\]^ Therefore, these changes in the musculoskeletal system may result in height loss in subjects with low SES. However, the relationship between height loss and the musculoskeletal system by sex remains controversial. In some studies, including the current study, height loss was greater in women than in men.^\[[@R45],[@R46]\]^ Some studies of women found that kyphosis was associated with an increased risk of fracture,^\[[@R47]\]^ and self-reported height loss (2.4 cm) has been observed in elderly women with severe kyphosis.^\[[@R48]\]^ However, another study proposed that the prevention of osteoporosis and fracture using medical treatment and intervention might reduce height loss in women more effectively than in men, especially in women with a height loss \>5 cm.^\[[@R49]\]^ Although the cause of height loss in men has not yet been reported, Szulc et al^\[[@R50]\]^ found an association between sarcopenia and poor bone structure and between sarcopenia and bone loss in elderly men.

Height loss may be associated with SES, independent of other factors. In the China Longitudinal Healthy Longevity Study, SES was an important predictor of height loss,^\[[@R25]\]^ and both education level and income were negatively associated with height loss. The authors suggested that subjects with a high SES had better health behaviors than those with a low SES. Moreover, subjects with a high SES would be more likely to use medical care facilities to maintain and improve their health and to ensure that they maintain a good nutritional status than subjects with a low SES.^\[[@R25],[@R51]\]^ Occupational type was also associated with height loss. Men aged ≥60 years employed in housework or agriculture showed greater height loss than men in high-skilled occupations; however, this association was not present in women.^\[[@R25]\]^

This study had some limitations. First, owing to its cross-sectional design, it was not possible to ascertain a causal relationship between SES and height loss. Second, we did not collect data regarding the SES of the subjects in their youth, and the SES in childhood may be associated with adult bone structure and height loss. Third, we did not assess the history of osteoporosis, fracture, or treatment, which are the causes of height loss, although this is controversial. Fourth, because we only included Korean subjects, our results might not be generalizable to other ethnic groups. Fifth, we only assessed the subjects' peak (maximum) height using a self-reported questionnaire, not by reference to written data; memory bias may have occurred. Nonetheless, Hiller et al^\[[@R7]\]^ found that self-reported maximum height is useful as a surrogate for baseline height.

However, this study had some strengths. To the best of our knowledge, it is the first study to examine height loss and the association between height loss and SES in Korean elderly. Therefore, the results of this study could be widely used in various clinical studies as basic data regarding height loss in the Korean elderly, especially as it relates to osteoporosis or treatment. Second, this study analyzed data for a sample representative of the Korean population. Third, measurement of height is easy and cost-free in almost any clinical setting. Therefore, it may be used widely as an indicator of related health problems.

In conclusion, height loss was associated with ≤6, 7--9, or 10--12 years of education in men and with low income level (iQ1) in both men and women. Height loss was more prevalent in men and women with low SES and less prevalent in men with a high SES than in men with a middle SES. Because height loss can be a predictor of poor health outcomes, physicians should monitor patients' height loss, especially in men with a low SES. Further prospective studies are needed to reveal the causal pathways between SES and height loss.
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